Patent: 5,580,776
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Summary for Patent: 5,580,776
| Title: | Modified hepatocytes and uses therefor |
| Abstract: | Genetically engineered or transduced hepatocytes which express genetic material of interest introduced or incorporated into them, as well as methods of producing, transplanting and using the genetically engineered hepatocytes. The genetic material of interest can be incorporated through use of a vector, such as a recombinant retrovirus, which contains the genetic material of interest, or by other means. |
| Inventor(s): | Wilson; James M. (Ann Arbor, MI), Mulligan; Richard C. (Cambridge, MA) |
| Assignee: | Howard Hughes Medical Institute (Chevy Chase, MD) Whitehead Institute for Biomedical Research (Cambridge, MA) |
| Application Number: | 08/201,721 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,580,776
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Sign Up | 2013-12-03 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
